Morton Dl

1.5k citations
47 papers · 1.2k indexed · 1 hit paper · h-index 16

Morton Dl

47 papers receiving 1.0k citations

Hit Papers

Demonstration of antibodies against human malignant melan...3211968202619872006100200300

Peers

Morton Dl
Comparison fields: 5 of 88
  • Oncology 693
  • Immunology 504
  • Dermatology 83
  • Immunology and Allergy 50
  • Radiology, Nuclear Medicine and Imaging 172
Replace Mark Egan with:
Mark Egan United Kingdom
Frederick M. Golomb United States
J. Anne Nizze United States
Black Mm United Kingdom
Gianfrancesco Gallino Italy
M. Drijkoningen Belgium
Henrik Griesser Germany
Ami B. Patel United States
Maury Rosenstein United States
E. Douglas Holyoke United States
Morton Dl relative to Mark Egan United Kingdom Mark Egan's profile →
Citations per field
00.5×2.9×
Mark Egan · 1×
Citations per year

Countries citing papers authored by Morton Dl

Since Specialization
Citations

This map shows the geographic impact of Morton Dl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morton Dl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morton Dl more than expected).

Fields of papers citing papers by Morton Dl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morton Dl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morton Dl. The network helps show where Morton Dl may publish in the future.

Co-authorship network

The 23 scholars most cited alongside Morton Dl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Morton Dl Line = papers co-authored together Morton Dl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present, and future.
200141
2
Vaccine therapy for patients with melanoma.
199930
3
Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes.
19906
4
In vitro sensitivity of breast carcinoma to combination chemotherapy.
19853
5
High-grade soft-tissue sarcomas of the extremity: UCLA experience with limb salvage.
198531
6
Hyperthermia: adjunctive modality for hepatic infusion chemotherapy.
19837
7
Immunologic aspects of unknown primary melanoma.
198016
8
Natural humoral immunity in patients with malignant disease.
19802
9
Specificity of antibody induced in sarcoma patients immunized with allogeneic sarcoma cells.
19803
10
The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study.
1978102
11
Polymorphonuclear leukocyte tumor cell cytotoxicity: a new method of quantitation.
19771
12
Induction of melanoma specific monocyte cytotoxicity in patients receiving BCG immunotherapy.
19772
13
Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
197714
14
Immunotherapy in malignant melanomaa.
19763
15
Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
197661
16
Cellular immunity to tumor-associated antigens in sarcoma patients and their relatives.
19752
17
Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
19724
18
Immunotherapy of human melanomas and sarcomas.
197216
19
Immunologic and immunotherapeutic studies with human sarcomas.
19702
20
Immunologic and virus studies with human sarcomas.
196979

About Morton Dl

Morton Dl is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Internal Medicine, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (19 papers), Cutaneous Melanoma Detection and Management (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Virus-based gene therapy research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer Research and Treatments (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Oncology (693 citations), Immunology (504 citations), Dermatology (83 citations), Immunology and Allergy (50 citations) and Radiology, Nuclear Medicine and Imaging (172 citations). Morton Dl has collaborated with scholars based in United States. Frequent co-authors include Holmes Ec, Malmgren Ra, Ketcham As, G. Schidlovsky, Richard Essner, Pond R. Kelemen, Stuart Sostrin, A E Giuliano, Peter J. Bostick and Roth Ja. Their work appears in journals such as American Journal of Roentgenology, International Journal of Oncology, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026